Request Your Free White Paper Now:

"What separates automation that accelerates progress from initiatives that fall flat?"

Download this white paper to learn more.

Across the pharma product lifecycle — from early discovery to manufacturing — industry leaders face intensifying pressure to move faster, streamline operations, ensure compliance and stay ahead of evolving regulations. But without a clear strategy, many automation efforts struggle to deliver meaningful impact.

This whitepaper reveals how forward-thinking organizations are reimagining automation — not as a one-off tool, but as an enterprise-wide enabler of speed, precision and patient impact. By grounding every initiative in purpose, process, and context of use, they’re turning complexity into a competitive advantage.

Inside, you’ll discover:

• Why automation efforts fail without a defined context of use (COU)
• How the FDA’s 2025 draft guidance supports responsible AI deployment
• Real-world strategies from industry leaders like Regeneron, Novartis and Sanofi
• Practical use cases across R&D, safety, regulatory and manufacturing
• How to align process, people, and technology for enterprise-scale impact

Whether you’re just beginning or optimizing mature systems, this paper offers a proven framework to scale automation confidently while staying compliant and patient-focused.

Download now to learn how strategic automation accelerates time-to-market and brings life-changing treatments to patients faster.

Offered Free by: Appian
See All Resources from: Appian